Biotechnology Market Analysis By Application, Technology And Segment Forecast Up To 2025

Global Biotechnology Market is expected to reach USD 727.1 billion by 2025, according to a new report by Grand View Research, Inc. The emergence of certain key themes in the biotechnology market is expected to drive growth in this industry to a lucrative extent.

These key themes include regenerative medicine and genetics in diagnostics. Presence of a plethora of companies focusing on the development of regenerative therapies is anticipated to drive sector growth through to 2025. Technological advancements pertaining to the penetration of artificial intelligence in this industry is expected to fuel progress with potential avenues. The companies are engaged in unleashing machine learning in order to understand individual cancer cases, while recommending clinical trials.

Supportive government (and its allied agencies) policies related to synthetic biology is a major growth impacting driver in this sector. Developed economies such as UK and the U.S. are critically monitoring and funding synthetic biology R&D initiatives. For example, in 2010, a six months’ review of synthetic biology headed by a panel of expert scientists was enforced by the U.S. President and subsequently conducted a hearing of the Energy and Commerce Committee exclusively concerning synthetic biology.

Full Research Report on global Biotechnology Market Analysis: http://www.grandviewresearch.com/industry-analysis/biotechnology-market

Further key findings from the report suggest:

• Owing to technological advancements and widespread application of this field in various aspects of healthcare, the health segment is expected to exhibit strong progress in the forecast period
• Continuous introduction of new biotechnological products to cater to healthcare entities that are involved in diagnosis, prognosis and biopharmaceutical development is estimated to propel the market
• Decreasing costs and rise in number of services in this segment are expected to drive segment with lucrative avenues
• North American pharmaceutical and biotech companies have experienced great success in the recent years resulting in larger share
• Introduction of technologically advanced products and presence of various biotechnology based programs such as the UC Davis Biotechnology Program, the University of California Biotechnology Research and Education Program are attributive to drive the growth of sector in the coming years
• Asia Pacific market is anticipated to grow at the most lucrative pace due to changing health care infrastructure in this region which drives the demand for these products
• Strong governmental support and recruitment of highly trained Chinese scientists with the support of their administration has made it possible for China to speedily build up capacity in area of regenerative medicine

• Key players operating include Gilead, Celgene, Abbott, Novo Nordisk A/S,Novartis AG, Sanofi Aventis, and Lonza

View more reports of this category by Grand View Research at: http://www.grandviewresearch.com/industry/biotechnology

Grand View Research has segmented the Global Biotechnology Market on the basis of technology, application, and region:

Biotechnology Technology Outlook (Revenue, USD Million; 2014 - 2025)

• DNA Sequencing
• Nanobiotechnology
• Tissue engineering and Regeneration
• Fermentation
• Cell Based Assay
• PCR Technology
• Chromatography Market
• Others

Biotechnology Application Outlook (Revenue, USD Million; 2014 - 2025)

• Health
• Food & Agriculture
• Natural Resources & Environment
• Industrial Processing
• Bioinformatics
• Others

Biotechnology Regional Outlook (Revenue, USD Million; 2014 - 2025)

• North America
• U.S.
• Canada
• Europe
• Germany
• UK
• Asia Pacific
• Japan
• China
• Latin America
• Brazil
• Middle East and Africa (MEA)
• South Africa

View Press Release Of This Report by Grand View Research: http://www.grandviewresearch.com/press-release/global-biotechnology-market                 

About Grand View ResearchGrand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more Information visit: www.grandviewresearch.com

Medical/ Diagnostic Imaging Market Is Expected To Grow At A CAGR Of 5.7% Over The Forecast Period 2014-2025

Global Medical Imaging Market is expected to reach USD 55.7 billion by 2025, according to a new report by Grand View Research, Inc. Augmenting investment by government and federal organizations for portable diagnostic devices, and increasing prevalence of numerous chronic as well as sedentary lifestyle diseases is expected to vitally impact the industry growth.

Funds and initiatives by government and private players is expected to benefit the market. For instance, based on the information provided by the Hindustan Times in 2016, the Indian Government has setup an agency for encouraging domestic manufacturers and regulated prices of the medical devices.

Along with rise in investments and funds in developing region, there is also a significant rise in fundings in the European countries such as the UK where USD 21.0 million was provided by the government in August 2015 for better development of new therapy, diagnostics and medical technologies. Such efforts across various countries worldwide, together, are anticipated to positively drive the market over the forecast period.

The Diagnostic imaging market is highly consolidated and is anticipated to witness various new product launches over the forecast period, which will vitally impact the revenue generation for the industry. For instance, the adoption of high slice technology in CT scanners is expected to drive revenue for the industry globally. As of 2016, high slice system includes 80, 128, 256, 320 and 640 slice system which are offered only by top vendors such as Toshiba, Siemens Healthineers, Philips and GE healthcare.

Full Research Report On Global Medical Imaging Market Analysis: http://www.grandviewresearch.com/industry-analysis/medical-imaging-systems-market

Further Key Findings From the Report Suggest:

• Based on product type, there are five segments, X-ray, computed tomography, ultrasound, MRI equipment, and nuclear imaging. The x-ray segment was identified as the largest and is expected to grow at a CAGR of over 3.0% during the forecast period.
• North America is one of the most lucrative region for medical imaging market owing to better infrastructure facilities as compared to emerging regions and high end purchasing power along coupled with reimbursement framework in the region. U.S is the dominating region owing to its large population base having insurance coverage, advancement in technology, aging population coupled with prevalence of chronic disease.
• Key performing companies include Philips Healthcare, GE Healthcare, Siemen Healthineers, and Toshiba Medical Systems. Other players include, Shimadzu Corporation, Varian Medical Systems, Aribex Corporation, and Ziehm Imaging, Inc.

View more reports of this category by Grand View Research at: http://www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the Global Medical/ Diagnostic Imaging Market on the basis of product, and region:

Medical Imaging Product Outlook (Revenue, USD Million, 2014 - 2025)

• X-ray

·         By product type

§  Stationary

§  Portable (Handheld, Mobile)

·         By technology

§  Analog

§  Computed radiology

§  Digital radiology

·         Computed Tomography (CT)

·         By product type

§  Stationary

§  Portable

·         By technology

§  Low slice scanners

§  Medium slice scanners

§  High slice scanners

·         Ultrasound equipment

·         By product type

§  Trolley/Cart Based

§  Compact/Portable

·         By technology

§  2D

§  3D/4D

§  Doppler

§  HIFU

§  Lithotripsy

·         MRI equipment

·         By product type

§  Closed

§  Open

·         By technology

§  High field

§  Medium field

§  Low field

·         Nuclear imaging

·         By technology

§  SPECT

§  PET

Medical Imaging Regional Outlook (Revenue, USD Million, 2014 - 2025)

• North America
• U.S.
• Canada
• Europe
• Germany
• UK
• Asia Pacific
• China
• Japan
• Latin America
• Brazil
• Mexico
• Middle East Asia
• South Africa
• Saudi Arabia

View Press Release Of This Report by Grand View Research: http://www.grandviewresearch.com/press-release/medical-imaging-systems                

About Grand View ResearchGrand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more Information visit: www.grandviewresearch.com

Adhesion Promoter Market Size Is Projected To Reach $5.21 Billion By 2024

Global Adhesion Promoter Market is expected to reach USD 5.21 billion by 2024, according to a new report by Grand View Research, Inc. Increasing demand for silane and silicone products to enable efficient transportation with greater fuel savings is likely to foster industry growth. 

The increasing industrialization in emerging economies such as Brazil, China, India and Mexico coupled with a growing automotive sector has prompted high demand for sustainable paints and coatings. Silane promoters, in particular contribute to extended material lifetime and boost resource usage especially in automotive paints. 

Rising consumer disposable income in these economies is also expected to contribute to high passenger car sales which in turn is crucial to industry growth. Growing environmental and regulatory pressure to reduce resource wastage and carbon emissions from the transportation sector is also likely to promote product demand. 

High demand for silane products such chlorosilanes and other alkoxysilanes on account of greenhouse gas (GHG) abatement effects is likely to foster silane growth. Silanes thus emerged as the largest product with around 34% market share in 2015. Maleic anhydride emerged as the fastest growing product with highest CAGR of 7.3% from 2016 to 2024. These additives provide durability and enhanced binding capabilities to composites, specifically providing strength & stability in the automotive & construction sector.  

Full Research Report on Global Adhesion Promoter Market Analysis:
http://www.grandviewresearch.com/industry-analysis/adhesion-promoter-market

Further key findings from the report suggest:

• Global adhesion promoter market size was708.1 kilotons in 2015 and is expected to reach 1,181.5 kilo tons by 2024, growing at a CAGR of 6.0% from 2016 to 2024
• Plastics & composites were the leading application segment and accounted for 32.9% of total market volume in 2015.Development of innovative polymer resin materials and high performance plastic composites is likely to lead to their usage in automotive, aerospace and marine transportation owing to their light weight and high strength.
• Technological advancements are expected to spur product demand in ‘green tires’ leading to growth in rubbers segment. China generated the highest demand for promoters in rubber segment accounting for over 17% of its consumption in 2015.
• North America and Europe present relatively mature markets with a combined share of around 39% in 2015. Highly developed countries such as the U.S., Canada, Germany, the UK, France and Italy witnessed high product penetration, presenting few opportunities to market participants over the forecast period.
• Adhesion promoters market is mainly dominated by multinational players such as BASF, Arkema, The 3M Company, Eastman Chemical Company, DuPont, Ashland, Momentive Performance Materials Inc., Dow Corning Corporation, Altana AG, Evonik Industries among several other independent players.

View more reports of this category by Grand View Research at:
http://www.grandviewresearch.com/industry/plastics-polymers-and-resins

Grand View Research has segmented the Global Adhesion Promoter Market on the basis of product, application and region:

Global Adhesion Promoter Product Outlook (Volume, Kilo Tons; Revenue, USD Million, 2014 - 2024)

• Silane
• Maleic anhydride
• Chlorinated polyolefins
• Titanate & zirconate
• Others

Global Adhesion Promoter Application Outlook (Volume, Kilo Tons; Revenue, USD Million, 2014 - 2024)

• Plastics &composites
• Paints &coatings
• Rubber
• Adhesives
• Metals
• Others

Global Adhesion Promoter Regional Outlook (Volume, Kilo Tons; Revenue, USD Million, 2014 - 2024)

• North America
• U.S
• Canada
• Mexico
• Europe
• Germany
• UK
• France
• Italy
• Asia Pacific
• India
• China
• Japan
• South Korea
• Central & South America
• Brazil
• Argentina
• Middle East and Africa

View Press Release Of This Report by Grand View Research: http://www.grandviewresearch.com/press-release/global-adhesion-promoter-market                        

About Grand View ResearchGrand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more Information visit: www.grandviewresearch.com

Ammonium Sulfate Market Is Projected To Reach $3.44 Billion By 2022

Global Ammonium Sulfate Market is expected to reach USD 3.44 billion by 2022, according to a new report by Grand View Research, Inc. Growing fertilizers demand on account of growing population and decreasing arable land is expected to remain a key driving factor for global ammonium sulfate market. Shift in trend towards increasing crop yield by increasing nutrient contents such as nitrogen and sulfur in soil is also expected to have a positive influence on the market growth. Presence of stringent regulatory norms particularly in developed markets of Germany, 

France, UK and the U.S. are expected to remain a key challenge for market participants.

Solid ammonium sulfate emerged as the leading product segment and accounted for over three quarters of total demand in 2014. Solid ammonium sulfate is also expected to witness highest growth of 2.45% from 2015 to 2022. Granular ammonium sulfate finds its application across a wide range of end-use industries which has contributed towards its growth.

Full Research Report on Global Ammonium Sulfate Market Analysis:
http://www.grandviewresearch.com/industry-analysis/ammonium-sulfate-market

Further key findings from the report suggest:

• Global ammonium sulfate market demand 24.60 million tons in 2014 and is expected to reach 29.81 million tons by 2022, growing at a CAGR of 2.43% from 2015 to 2022.
• Fertilizer emerged as the leading application segment and accounted for over 90% of total market volume in 2014. Continuous increase in population coupled with need to increase cultivation yield is expected to benefit the demand for ammonium sulfate in fertilizers. Novel applications such as food additives are expected to witness the highest growth of 2.90% from 2015 to 2022.
• Asia Pacific was the leading regional market with demand share estimated at 39.0% in 2014. Presence of a large agriculture industry in China, India and South East Asian countries is expected to remain a key driving factor for the regional market. The region is also expected to witness the highest growth of 2.57% from 2015 to 2022.
• Central and South America is expected to witness significant growth to account over 17% of the global market by 2022. Ammonium sulfate demand in Brazil is expected to rise over the forecast period and have positive impact on the overall regional market.
• Ammonium sulfate industry is fragmented with presence of large number significant market players across the globe. Some leading companies operating in the global market include DSM, Honeywell and BASF. Other companies include Sumitomo Chemicals, Helm AG, Evonik Industries, Domo Chemicals, AkzoNobel, Lanxess, Rentech and Agrium.

View more reports of this category by Grand View Research at:
http://www.grandviewresearch.com/industry/agrochemicals-and-fertilizers

Grand View Research has segmented the Global Ammonium Sulfate Market on the basis of product, application and region:

Global Ammonium Sulfate Product Outlook (Volume, Kilo Tons; Revenue, USD Million, 2012 - 2022)

• Solid
• Liquid

Global Ammonium Sulfate Application Outlook (Volume, Kilo Tons; Revenue, USD Million, 2012 - 2022)

• Fertilizers
• Food Additives
• Industrial Use
• Others

Global Ammonium Sulfate Regional Outlook (Volume, Kilo Tons; Revenue, USD Million, 2012 - 2022

• North America
• U.S
• Canada
• Europe
• Germany
• France
• UK
• Spain
• Italy
• Asia Pacific
• India
• China
• Japan
• South Korea
• Central & South America
• Brazil
• Middle East and Africa
• Saudi Arabia

View Press Release Of This Report by Grand View Research: http://www.grandviewresearch.com/press-release/global-ammonium-sulfate-market                       

About Grand View ResearchGrand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more Information visit: www.grandviewresearch.com

Regulatory Affairs Outsourcing Market Is Anticipated To Reach $12.4 Billion By 2025

Global Regulatory Affairs Outsourcing Market is expected to reach USD 12.4 billion by 2025, according to a new report by Grand View Research, Inc. Outsourcing of regulatory affairs functions to CROs or other individual service providers offers life science companies the benefit to achieve cost efficiency and reduce the overall approval process time by eliminating delays associated with regulatory submission requirements. These benefits are primarily driving the outsourcing trend and hence impacting the market over the forecast period.

The augmenting disease prevalence in Asia Pacific and MEA regions and increasing number of clinical trials being conducted is stimulating life science companies to expand into these regions thereby increasing the demand of these services. Changing regulatory landscape especially in developing regions and stringent directive requirements in developed regions such as North America and Europe are driving the adoption of outsourcing trend in regulatory affairs function. Growth in emerging areas such as biosimilars and orphan drug is expected to stimulate the demand for regulatory expertise thereby contributing to the growth of regulatory affairs outsourcing market.

Full Research Report on Global Regulatory Affairs Outsourcing Market Analysis:
http://www.grandviewresearch.com/industry-analysis/regulatory-affairs-outsourcing-market

Further Key Findings From The Study Suggest:

• Based on product, legal representation is expected to witness lucrative growth during the forecast period owing to healthcare reforms especially in emerging regions such as India and China. Also, rising demand of legal representation in regions such as Europe for gaining market authorization for companies who do not have an established base in the region. For instance, small or mid-size biopharmaceutical companies having domestic only, requires legal representative if they want to expand their presence in European countries such as UK and Germany. Regulatory writing and publishing is expected to be the leading segment during the forecast period.
• Few of the industry players for the regulatory affairs outsourcing market are Clinical Research, Clinilabs Inc., Criterium Inc., PRA International, Promedica International, Wuxi AppTec, Medpace Inc.The other major players include Pharmaceutical Product Development(PPD), PAREXEL International Corporation, Charles River Laboratories International Inc., and Covance Inc.
• There has been a trend of strategic partnership between services providers for increasing service portfolio or expanding regional presence. For instance, PPD formed a joint venture with Shin Nippon Biomedical Laboratories Ltd. (SNBL), leading provider of development services to biopharmaceuticals, to provide clinical development services in Japan including function based services such as regulatory and pharmacovigilance.

View more reports of this category by Grand View Research at:
http://www.grandviewresearch.com/industry/pharmaceuticals

Grand View Research has segmented the Global Regulatory Affairs Outsourcing Market on the basis of service, and region:

Regulatory Affairs Outsourcing Product Outlook (Revenue, USD Million; 2014 - 2025)

• Regulatory consulting
• Legal Representation
• Regulatory writing and publishing
• Product registration and clinical trial applications
• Others

Regulatory Affairs Outsourcing Regional Outlook (Revenue, USD Million; 2014 - 2025)

• North America
• U.S.
• Canada
• Europe
• Germany
• UK
• Asia Pacific
• China
• Japan
• India
• Latin America
• Mexico
• Brazil
• MEA
• South Africa
• Saudi Arabia

View Press Release Of This Report by Grand View Research: http://www.grandviewresearch.com/press-release/global-regulatory-affairs-outsourcing-market                      

About Grand View ResearchGrand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more Information visit: www.grandviewresearch.com

Thermoplastic Polyester Elastomer (TPEE) Market Is Projected To Reach $1.49 Billion By 2025

Global Thermoplastic Polyester Elastomer (TPEE) Market is expected to reach USD 1.49 billion by 2025, according to a new report by Grand View Research, Inc. Progress in plastics technologies & compounding or processing capabilities are expected to complement industry growth over the forecast period. 

Thermoplastics polyester resins combine excellent electrical, mechanical, and thermal properties with high dimensional stability & chemical resistance among other advantageous characteristics. Growing penetration of bio-based feedstock from renewable resources such as biomass has had a significant impact on sustainable consumption patterns in the market.

Significant growth in end-use industries such as automotive, construction, industrial manufacturing, electrical & electronics, consumer goods and others in emerging economies is a major factor driving TPEE demand. The value chain consists of raw material manufacturers producing ethylene, methacrylic acid and SBS rubber, which are highly dependent upon crude oil supply and challenge suppliers.

Increasing R&D activities by numerous companies involved in the production, distribution and recycling of TPEE compounds are expected to drive investments in the market and boost growth. New entrants are likely to be compelled to innovate in order to compete with existing multinational companies and gain a foothold in the market.

Automotive emerged as the dominant end-use market with over 42% of the volume share in 2016. TPEE materials that foster higher performance of components such as airbag accessories, lock assemblies, door handle seals, silencer gears and others are anticipated to drive industry growth over the forecast period.

Full Research Report on Global Thermoplastic Polyester Elastomer Market (TPEE) Market Analysis: 
http://www.grandviewresearch.com/industry-analysis/thermoplastic-polyester-elastomer-tpee-market

Further key findings from the report suggest:

• The global thermoplastic polyester elastomer market exceeded 230 kilo tons in 2016 and is expected to grow at a CAGR of 4.9% from 2016 to 2025
• Increasing consumer interest in miniaturized and ‘smart’ wearable electronics has driven TPEE consumption in this segment. The electrical & electronics end-use market is likely to account for about USD 290 million by 2025, growing at CAGR of 6.2% from 2017 to 2025.
• Rising expenditure on healthcare and medical facilities is another driving factor with expanding geriatric population across developed economies and numerous epidemic breakouts in recent years. The compound is widely used in the production of medical devices, equipment and even surgical instruments owing to its high safety features & sustainability.
• The U.S. is anticipated to remain a major market in the industry on account of the high levels of industrialization and concentrated large players present in the country
• China is also anticipated to remain a dominant player with increasing investments in the region’s industries such as automotive, construction, medical and electronics. Rising disposable income is also expected to play a key role in developed TPEE production capabilities as consumers invest higher levels in advanced goods.
• The industry is fragmented in nature with large multinationals occupying dominant position in the market such as DuPont, A. Schulman, BASF, Ashland, Covestro, SABIC, Mitsubishi Chemicals and others. Smaller to medium sized players occupy a relatively minor share with limited product portfolios and presence.

View more reports of this category by Grand View Research at:
http://www.grandviewresearch.com/industry/plastics-polymers-and-resins

Grand View Research has segmented the Global Thermoplastic Polyester Elastomer Market (TPEE) Market on the basis of end-use, and region:

Thermoplastic Polyester Elastomer End-use Outlook (Volume, Kilo Tons; Revenue, USD Million, 2014 - 2025)

• Automotive
• Electrical & Electronics
• Industrial
• Medical Devices
• Consumer Goods
• Others

Thermoplastic Polyester Elastomer Regional Outlook (Volume, Kilo Tons; Revenue, USD Million, 2014 - 2025)

• North America
• U.S.
• Canada
• Mexico
• Europe
• Germany
• UK
• France
• Italy
• Asia Pacific
• China
• India
• Japan
• Central & South America
• Brazil
• Middle East & Africa
• Saudi Arabia

View Press Release Of This Report by Grand View Research: http://www.grandviewresearch.com/press-release/global-thermoplastic-polyester-elastomer-tpee-market                     

About Grand View ResearchGrand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more Information visit: www.grandviewresearch.com

Melanoma Therapeutics Market Size Is Expected To Reach $12.4 Billion By 2025

Global Melanoma Therapeutics Market is expected to reach USD 12.4 billion by 2025, according to a new report by Grand View Research, Inc. Increasing incidence of chronic diseases such as melanoma, skin cancer, and skin allergies is an important driver of the market.

According to CDC, over 71,943 people were affected by melanoma in 2013. The American Cancer Society estimates that this number will go up to 87,100 in 2017, thus highlighting the need for melanoma drugs over the forecast period.

Increasing number of FDA approvals and introduction of novel therapeutics with enhanced efficacy are also anticipated to present growth opportunities. Within a period of 6 years, i.e., from 2011 to 2016, around eight biologics have been approved for the treatment of this disease, which include Opdivo, Yervoy, Cotellic, Zelboraf, Keytruda, Mekinist, Tafinlar, and Imlygic.

Companies are undertaking various R&D activities to find new indications for existing products and development of innovative molecules. For instance, in September 2014, the U.S. FDA approved patented drug Keytruda (Merck & Co., Inc.) to treat metastatic melanoma, thereby extending the therapeutic application of its product. This drug was initially approved for treatment of non-small cell lung cancer.

Furthermore, many pharmaceutical companies in the U.S., Europe, and Asia Pacific are focusing on development of new biologics. For instance, in March 2017, Daiichi Sankyo Company, Limited announced a collaborative drug discovery project—Take a New challenge for Drug discovery (TaNeDS)—to facilitate new drug development through collaborations. Moreover, it entered into a strategic research collaboration with AgonOX, Inc. to develop new immunotherapy drugs for the immuno-oncology segment. Approval of novel products over the forecast period is anticipated to boost market growth.

Full Research Report on Global Melanoma Therapeutics Market Analysis:
http://www.grandviewresearch.com/industry-analysis/melanoma-therapeutics-market

Further Key Findings From the Study Suggest: 

• Targeted therapy segment is expected to show lucrative growth owing to benefits such as low adverse effects and higher efficiency
• Branded drugs held a dominant share of the industry because of patent exclusivity
• Biologics, such as Opdivo and Cotellic, are expected to exhibit lucrative growth over the forecast period owing to increase adoption and advantages such improved therapeutic effects
• The patent for Yervoy will expire in 2022 in the U.S. and in 2020 in Europe. This is expected to provide growth opportunities for new market entrants
• Asia Pacific is expected to exhibit lucrative CAGR over the forecast period
• Key market players are increasing R&D efforts for discovery and development of novel drugs for the treatment of melanoma

View more reports of this category by Grand View Research at:
http://www.grandviewresearch.com/industry/pharmaceuticals

Grand View Research has segmented the Global Melanoma Therapeutics Market on the basis of therapy, drugs, and region:

Melanoma Therapeutics Therapy Outlook (Revenue, USD Million, 2014 - 2025)

• Chemotherapy
• Immunotherapy
• Targeted Therapy
• Radiation Therapy

Melanoma Therapeutics Drugs Outlook (Revenue, USD Million, 2014 - 2025)

• Opdivo
• Yervoy
• Mekinist+Tafinlar
• Keytruda
• Cotellic
• Zelboraf
• Imlygic
• Generics

Melanoma Therapeutics Regional Outlook (Revenue, USD Million, 2014 - 2025)

• North America
• U.S.
• Canada
• Europe
• Germany
• UK
• Asia Pacific
• Japan
• China
• India
• Latin America
• Brazil
• Mexico
• MEA
• South Africa

View Press Release Of This Report by Grand View Research: http://www.grandviewresearch.com/press-release/global-melanoma-therapeutics-market                    

About Grand View ResearchGrand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more Information visit: www.grandviewresearch.com